Clinical Trial Update: SSRI and Buprenorphine [Phase 3]

View source ↗

Summary

Phase 3 trial of an SSRI in combination with buprenorphine for opioid dependence with comorbid depression has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Opioid Dependence

Drugs mentioned

• SSRI (selective serotonin reuptake inhibitor) (selective serotonin reuptake inhibitor)
• buprenorphine (buprenorphine)

Snippet

Sponsor: Butler Hospital | Conditions: Opiate Dependence, Depression | Phase 3 | Status: COMPLETED | Results posted: 2012-04-03